Aim
Obtain analysis results faster while improving research productivity, reproducibility, and auditability with a modern environment for managing data pipelines at scale.Challenges
- →Need to accelerate analysis pipelines.
- →Make pipelines accessible to scientific users.
- →Improve cloud resource use efficiency.
- →Ensure reproducibility and auditability.
— Yohann Potier, Director of Data Platforms
Solution
Nextflow
Simplify the writing and deploying compute and data-intensive pipelines at scale on any infrastructure.
Seqera
Management solution for Nextflow workflows designed to enable collaborative data analysis at scale.
Results
- →Increased analysis capacity. Having the capacity to run large numbers of analysis jobs quickly is a critical enabler. With faster turnaround times, researchers can analyze promising therapeutics more quickly. The mature AWS Batch integration also means that pipelines are more efficient, and reliable.
- →Dramatic productivity gains. The Seqera interface makes pipelines exceptionally easy to launch, monitor, and study results saving time at all stages in the data analysis workflow.
- →Better visibility into pipelines and data. Approximately ten people regularly use Seqera to launch and manage analysis jobs at Tessera. With Seqera, users have full visibility to all pipeline runs, subject to permissions.
- →Reduced cloud spending. By using the AWS Batch executor, Tessera has also been able to reduce cloud spending, by maximizing their use of spot instances, packing pipeline tasks more efficiently on machine instances, and deploying cloud resources only when they are needed.
About
Tessera Therapeutics are the innovators behind Gene Writing and Gene Rewriting, new biotechnologies designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, with the potential to treat and cure diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building on recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy.
To learn more, visit https://www.tesseratherapeutics.com/